In evaluating the anti-tumour efficiency of cytostatic drugs, clinicians measure tumour size at clinical examination, or use radiological, echographical or CT-scanning techniques. Tumour size, however, decreases only with some delay after drug administration, whereas drugs begin to act as soon as they are administered. Although tumour markers are certainly useful in specific cases, there is a need for early and accurate methods for measuring drug efficiency in cancer patients, which could possibly result in improved administration techniques. These methods could be based upon the measurement of various physiological parameters, such as tumour temperature; the latter revealing the intensity of the tumour cellular metabolism, as well as the importance of the tumour vascular output (Gautherie et al., 1975a,b) . Both these factors seem to be closely linked.
Some investigators have already shown the relationship between the malignancy of mammary tumours and their heat production (Gautherie et al., 1975a, b; Moller & Bojsen, 1980) . Moreover, radiotherapy induces a hypothermic phase in the responding tumours (Gautherie et al., 1975c) . Thus, the decreased malignant potential of the tumours, which is induced by the administration of cytostatic drugs might be expressed by tumour hypothermia as has been recently demonstrated in rats by inducing regression of the ISIS 130 and ISIS 208 immunocytomas with cyclophosphamide (Nickers et al., 1986) .
In this study, the external temperature of the very chemosensitive ISIS 130 tumour was investigated after treatment with increasing doses of different cytostatic drugs. The possible relationship between the thermic behaviour of this tumour and the reduction in surface area induced by the drugs was examined.
Materials and methods Animals and tumour transplantation LOU rats from our own substrain (LOU/dec) were used. These were kept in cages of 4 animals and in an artificial cycle of dark periods (7p.m.-7a.m.) and light periods (7a.m.-7p.m.). They were given a commercial pelleted diet (type A03-U.A.R., Villemoison-sur-Orge, France) as well as water ad libitum. The temperature of the room in which they stayed from the day of tumour engraftment till the end of the experiment, was kept constant between 210 and 22°C.
Immunocytoma ISIS 130 was used (Deckers et al., 1973 (Deckers et al., , 1977 the untreated rats after injection of malignant cells as described initially (Deckers et al., 1973 (Deckers et al., , 1977 This method allowed us to measure the temperatures to an accuracy of 0.1°C. We have recorded the thermal behaviour of the tumour using the DELTA T (DT) obtained after subtracting RT and TT (DT=TT-RT).
Tumour treatment As soon as the tumours reached an average surface of 950 mMn2, the hair was removed under anaesthesia (with a 2% 2,2,2-tribromoethanol solution) with an epilating cream, without inducing cutaneous trauma. The rats were then distributed, according to the size of the tumour surface, into groups of 12 individuals. The mean values were equal in every group, being 950 mm2 (with a standard deviation of 200 mm2 in each group). The day of epilation was considered to be day 1 of the experiment, and from this time on, measurements of the tumour surfaces were made every day at 11 a.m., while the thermal measurements were initiated on day 2 at 6p.m. After this, they were taken at 7a.m. and 6-p.m. every day till the end of the experiment. The cytostatic drugs were administered on day 4, at 12a.m., in a single i.v. injection (tail vein). Untreated rats were injected with physiological saline only. Table I shows the various doses (mgm-2) of the different cytostatic drugs administered. Each dose was tested in a group of 12 rats. The administered doses of each drug ranged from dose zero (untreated rats) to a low dose having no effect upon the tumour, up to a 
Measurement of drug-induced tumour regression and TT decrease
The size of tumour surface prior to the administration of the cytostatic drugs, represents the reference value, from which the reference line RLI) was drawn ( Figure IA) . The temporal integration (F(S)) of the surface between RL1 and the curve of the measured surfaces at a later time was used to quantify the effective response to the cytostatic drugs. The greater the decrease in tumour size, the larger was the increase in F(S). As tegards the temperature measurements, the mean value of the first four DT preceding the administration of the cytostatic agents (two of them having been taken at 7a.m. and two at 6p.m.) represents the reference value, from which the reference line (RL2) has been drawn ( Figure iB) . The temporal integration (F(T)) of the surface between RL2 and the curve of the DT obtained later on was used to quantify the thermal response of the tumour to chemotherapy.
Results For every cytostatic drug tested, negative or zero DT were observed throughout these experiments (in the range from -4°to 0WC), indicating that TT was equal to or lower than RT ( Figure IB) . Any drop in the DT lines ( Figure 1B) decrease in TT and DT values was, after the administration of the cytostatic drugs, the larger was the increase of the F(T) values (Figure 1) . Figure 2 shows the relationship between the dose and the tumouricidal effect, as expressed by the parameters F(T) or F(S) for the different cytostatic drugs. The maximal tumouricidal effect of cisplatinum and cyclophosphamide was obtained with the respective doses of 3.5 and 25mgm-2. At lower doses and with other cytostatic drugs, a linear relationship existed between the dose and the parameters F(T) and F(S).
The calculation of the correlation coefficient (r) showed that the link between F(T) and F(S) was highly significant for vinblastine as well as for the other cytostatic drugs; r was positive in all five cases (Table II) . Further statistical analysis (linearity test) allowed us to consider the link between I F(T) and F(S) to be linear in all of the five cases considered. Figure 3 represents the linear relationship between F(T) and F(S) for each of the 5 drugs. No significant difference was found between the slopes of these straight lines, which are in fact superimposable; the relationship between the thermal decrease and the reduction of the tumour surface may therefore be represented by the same straight line, for whichever cytostatic drug was tested. Table III and Figure lb show for every administered cytostatic drug, the link between the magnitude of the F(T) parameters and the delay in tumour regrowth. The higher the value F(T), the longer the delay in tumour regrowth. Increasing doses of methotrexate, vinblastine and doxorubicin are correlated with increasing F(T) values and delay in tumour regrowth whereas with increasing doses of cis-platinum and cyclophosphamide a maximum F(T) value and the longest delay in tumour regrowth are attained with respective doses of 3.5 mgm-2 and 50 mgm-2 (Table III) .
As tumours regrow, the superficial temperatures and D(T) parameters rise to previous levels or become higher than before chemotherapy with negative F(T) values (Figure lb) .
The decrease in DT, followed by its increase to previous levels predict respectively the decrease in size and the regrowth of tumours treated with vinblastine ( Figure 1 ) and cis-platinum. The experimental tumour ISIS 130 has been investigated in the present study, because of its high sensitivity to cytostatic drugs of different classes.
Thus, we have demonstrated that the analysis of the transient external hypothermia occurring in this subcutaneous tumour after chemotherapy (and shown by a decrease in the DT values and increase in F(T) values) allowed us to measure the efficiency of various cytostatic drugs.
For whatever drug used, the same linear relationship between the F(S) and F(T) parameters was noted. External hypothermia of this tumour after effective chemotherapy is therefore not linked to any particular type of cytostatic agent; its extent depends on the importance of the tumouricidal effect which has been achieved.
The decrease in DT, followed by the increase to previous levels predicts respectively the decrease in size and the regrowth of tumours treated with vinblastine and cis-platinum.
The temperature of the subcutaneous tumours could be measured equally with intra-tumoural probes or probes placed upon the tissue covering F(S) (Arbitrary units) Figure 3 The linear relationship between F(T) and F(S) for five cytostatic drugs. There is no significant difference between the slopes of these straight lines, which are superimposable. (Gautherie et al., 1975a, b) . The external temperatures are, of course, lower than the intra-tumour ones, but both these parameters show parallel variations by night and day (Gautherie et al., 1975a, b; Moller & Bojsen, 1980) . The same parallel variation occurs, when tumour hypothermia indicates a tumour response to radiotherapy (Gautherie et al., 1975c) . Temperature measurement with external probes is limited to superficial neoplasms, but has the advantage of being simple and avoiding the risks of inflammation and necrosis of the tumour tissue around the catheter (Moller et al., 1980) . Both factors are extremely important for small volume tumours, such as those which are handled in animal experiments. Moreover, in contrast to intra-tumour measurements, the ease of external temperature measurements allows us to determine the relationship between the doses of cytostatic drugs and the parameters F(T) and F(S) with large numbers of rats. Finally, the thermal significance of the peritumoural vascularization of small volume experimental tumours seems to be negligible (Moller et al., 1980) . The temperature of a tumour depends on the temperature of the grafted organism, on the tumoural cellular metabolism and the vasculature. The latter factors appear to be closely linked, but measurement of the intra-or extra-tumoural temperatures does not allow us to determine accurately the respective fractions of the vascular and metabolic components of the tumour temperature.
The application of the DT parameters allows us to eliminate the influence of the general temperature of the grafted organism. These DT parameters certainly appeared to be the most stable thermal parameters in untreated control rats throughout the experiments performed (Nickers et al., 1986) .
How can the phenomenon of transient tumour hypothermia be explained? Several authors have demonstrated a relationship between the inalignancy grade of mammary tumours and their internal and external temperature (Gautherie et al., 1975a) . Moreover, radiotherapy induces a hypothermic phase in the responding tumours (Gautherie et al., 1975c) .
Transient external hypothermia in the ISIS 130tumour characterizes the response to the different cytostatic drugs. This external hypothermia thus reveals the tumouricidal effect of the cytostatic drugs as well as the transient paralysis of tumour physiology.
The confirmation of these data in other experimental tumours as well as in human tumour xenografts could lead clinically to a rapid and noninvasive method of estimating the importance and duration of action of the cytostatic drugs against external tumours, such as those of head and neck and breast as well as sarcomas, adenopathies and probably bone metastases.
